Johnson And Johnson and AstraZeneca

Search results

- Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer...
  WKBN 27 Youngstown· 6 days ago
  Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing ...
- Court backs drugmakers in limiting 340B distribution
  Becker’s Hospital Review· 6 days ago
  Three judges for the U.S. Court of Appeals for the Washington, D.C. Circuit ruled May 21 in favor of drug manufacturers' ability to limit sales and distribution of discounted drugs in the government's ...
- Supreme Court Must Reverse Ruling Thwarting Patent Term Guarantees
  Bloomberg Law· 6 days ago
  The Federal Circuit’s decision to expand the scope of a judge-created rule for invalidating certain patents may impact nearly half of US patents and is likely to cost US biopharma and technology ...
- DC Circuit Sides With Manufacturers in '340B' Drug Discount Dispute | National Law Journal
  Law.com· 7 days ago
  The U.S. Court of Appeals for the D.C. Circuit on Tuesday backed manufacturers’ policies that limit...
- D.C. Circuit Holds 340B Program Does Not Prohibit Drug Manufacturers from Imposing Contract Pharmacy...
  JD Supra· 4 days ago
  In the latest legal development in the ongoing 340B contract pharmacy litigation, the United States Court of Appeals for the District of Columbia Circuit ruled earlier this week that the 340B ...